CNBC's Huckman On Weight Loss/Diabetes Drug
We're keeping an eye on shares of Sanofi-Aventis . The company says a new study finds its acomplia weight loss drug can also help diabetes. CNBC's pharmaceutical reporter Mike Huckman had the details on "Squawk on the Street."
Huckman says acomplia could help control type 2 diabetes--and that test results also showed the raising of good cholesterol-by up to 16%. The drug could provide up to $5 billion dollars in sales revenues. The drug helps weight loss by curbing the appetite.
There's also another possibility for acomplia. Sanofi-Aventis might consider further tests with the drug to help stop smoking.